VA to provide free overdose rescue drugs to veterans, barring employment retaliation
S. 3758 — End Veterans Overdose Act of 2026 · Filed by Jeanne Shaheen (D-NH) · 1 cosponsor · Introduced Feb 2, 2026 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the VA to provide opioid overdose rescue medications (like naloxone) free and without prescription to veterans and their designated caregivers at VA pharmacies. The VA must also provide drug information with each medication, limit data collection to what is necessary for delivery, and prohibit using that data against veterans for employment or as evidence of drug use. The VA must report to Congress within two years and annually thereafter on uptake, feasibility of expanding to family members and non-VA providers, and utilization trends.
Why we flagged it
The bill's core mechanism is a direct public-health intervention: free, accessible overdose rescue medication for a high-risk population. It is not a regulatory carve-out, subsidy, or commemorative measure—it is a straightforward expansion of VA health services.
What the text implies
- The prohibition on using medication data for employment or as evidence of drug use may create a tension with VA disability benefits determinations, which sometimes rely on substance-use history. The bill does not clarify how this data wall interacts with other VA processes.
- Expansion to non-VA providers (assessed in the report) could shift costs to private health systems or create coordination challenges if not funded adequately.
The full analysis lists 3 implications of this text.
Who stands to gain
pharmaceutical manufacturers of naloxone and other opioid overdose rescue medications